JP2024506953A5 - - Google Patents
Info
- Publication number
- JP2024506953A5 JP2024506953A5 JP2023549892A JP2023549892A JP2024506953A5 JP 2024506953 A5 JP2024506953 A5 JP 2024506953A5 JP 2023549892 A JP2023549892 A JP 2023549892A JP 2023549892 A JP2023549892 A JP 2023549892A JP 2024506953 A5 JP2024506953 A5 JP 2024506953A5
- Authority
- JP
- Japan
- Prior art keywords
- weeks
- subject
- psoriasis
- week
- test drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163150204P | 2021-02-17 | 2021-02-17 | |
| US63/150,204 | 2021-02-17 | ||
| US202163260322P | 2021-08-17 | 2021-08-17 | |
| US63/260,322 | 2021-08-17 | ||
| US202163261523P | 2021-09-23 | 2021-09-23 | |
| US63/261,523 | 2021-09-23 | ||
| US202263266535P | 2022-01-07 | 2022-01-07 | |
| US63/266,535 | 2022-01-07 | ||
| PCT/US2022/016819 WO2022178144A1 (en) | 2021-02-17 | 2022-02-17 | Remittive effects of tapinarof in the treatment of plaque psoriasis, atopic dermatitis, or radiation dermatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024506953A JP2024506953A (ja) | 2024-02-15 |
| JP2024506953A5 true JP2024506953A5 (https=) | 2024-03-22 |
Family
ID=82900200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023549892A Pending JP2024506953A (ja) | 2021-02-17 | 2022-02-17 | Ｐｌａｑｕｅ乾癬、アトピー性皮膚炎、放射線性皮膚炎の治療におけるタピナロフの改善効果 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20240315985A1 (https=) |
| EP (1) | EP4294518A4 (https=) |
| JP (1) | JP2024506953A (https=) |
| AU (1) | AU2022223701A1 (https=) |
| CA (1) | CA3208742A1 (https=) |
| WO (1) | WO2022178144A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11497718B2 (en) | 2018-11-13 | 2022-11-15 | Dermavant Sciences GmbH | Use of tapinarof for the treatment of atopic dermatitis |
| JP2025532421A (ja) * | 2022-10-10 | 2025-09-29 | 上海澤徳曼医薬科技有限公司 | 潰瘍を予防及び又は治療するためのスチルベン誘導体の使用 |
| WO2024125500A1 (zh) * | 2022-12-14 | 2024-06-20 | 上海泽德曼医药科技有限公司 | 一种局部药物组合物及其在医药上的应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT3297605T (pt) * | 2015-05-21 | 2022-05-30 | Dermavant Sciences GmbH | Composições farmacêuticas tópicas |
| US11497718B2 (en) * | 2018-11-13 | 2022-11-15 | Dermavant Sciences GmbH | Use of tapinarof for the treatment of atopic dermatitis |
| US20200147000A1 (en) * | 2018-11-13 | 2020-05-14 | Dermavant Sciences GmbH | Use of tapinarof for the treatment of chronic plaque psoriasis |
-
2022
- 2022-02-17 US US18/546,880 patent/US20240315985A1/en active Pending
- 2022-02-17 JP JP2023549892A patent/JP2024506953A/ja active Pending
- 2022-02-17 AU AU2022223701A patent/AU2022223701A1/en active Pending
- 2022-02-17 EP EP22756938.1A patent/EP4294518A4/en active Pending
- 2022-02-17 CA CA3208742A patent/CA3208742A1/en active Pending
- 2022-02-17 WO PCT/US2022/016819 patent/WO2022178144A1/en not_active Ceased
- 2022-02-17 US US17/674,577 patent/US20220265572A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12569453B2 (en) | Use of tapinarof for the treatment of atopic dermatitis | |
| Graft et al. | A placebo-and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray | |
| US20230106782A1 (en) | Use of tapinarof for the treatment of chronic plaque psoriasis | |
| JP2024506953A5 (https=) | ||
| Vasileva et al. | Aetiology, diagnosis, and clinical management of vulvodynia | |
| US20240315985A1 (en) | Remittive effects of tapinarof in the treatment of plaque psoriasis, atopic dermatitis, or radiation dermatitis | |
| US20220395472A1 (en) | Remittive effects of tapinarof in the treatment of plaque psoriasis, atopic dermatitis, or radiation dermatitis | |
| AU2024204716A1 (en) | Treatment of alopecia areata | |
| Cohen | Dyshidrosiform bullous pemphigoid: case reports and review | |
| JP2021510159A (ja) | セルドゥラチニブ含有局所皮膚医薬組成物およびその使用 | |
| TW202406553A (zh) | 前額纖維化禿髮之治療 | |
| JP2019532112A (ja) | 結節性痒疹の治療方法 | |
| Ryan | Psoriasis: characteristics, psychosocial effects and treatment options | |
| KR20200097297A (ko) | Pde-4 억제제의 국소 연고 제형 및 피부 병태 치료에서의 이의 용도 | |
| JP2020520927A (ja) | 表皮水疱症の治療および防止におけるコエンザイムｑ１０製剤の使用 | |
| Malakar et al. | Acyclovir can abort rejection of punch grafts in herpes-simplex-induced lip leucoderma | |
| KR20260027115A (ko) | 타피나로프를 사용하여 아토피 피부염을 치료하는 방법 | |
| Buchanan et al. | Prescribing in dermatology | |
| GB2616294A (en) | Composition for use | |
| Putri et al. | Allergic Skin Disease in Elderly at Dr. Soetomo General Academic Hospital Surabaya (2019-2021) | |
| HK40003409A (en) | Treatment of prurigo nodularis | |
| Alonso-Pérez et al. | FC01 FREE COMMUNICATIONS ACNE, ROSACEA AND INFECTIONS | |
| HK1257770B (en) | Treatment of alopecia areata |